Flubendazole, FDA-approved anthelmintic, elicits valid antitumor effects by targeting P53 and promoting ferroptosis in castration-resistant prostate cancer-Reference-Cited by-同舟云学术

Flubendazole, FDA-approved anthelmintic, elicits valid antitumor effects by targeting P53 and promoting ferroptosis in castration-resistant prostate cancer

Published:2021-02 Issue: Volume:164 Page:105305
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Zhou Xumin,Zou Libin,Chen Wenbin^ORCID,Yang Taowei,Luo Junqi,Wu Kaihui,Shu Fangpeng,Tan Xiao,Yang Yu,Cen Shengren,Li Chuanyin,Mao Xiangming^ORCID

Funder

Guangzhou Municipal Science and Technology Project

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology

Reference47 articles.

1. Cancer statistics, 2020;Siegel;CA Cancer J. Clin.,2020

2. Androgen deprivation therapy for prostate cancer;Singer;Expert Opin. Pharmacother.,2008

3. Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis;Scher;J. Clin. Oncol.,2005

4. Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer;Watson;Nat. Rev. Cancer,2015

5. Comparative performances of flubendazole and albendazole in cystic echinococcosis: ex vivo activity, plasma/cyst disposition, and efficacy in infected mice;Ceballos;Antimicrob. Agents Chemother.,2011

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic intravesical instillation for bladder cancer: CRISPR-Cas13a and fenbendazole combination therapy;Journal of Experimental & Clinical Cancer Research;2024-08-12

2. Recent progress of ferroptosis in cancers and drug discovery;Asian Journal of Pharmaceutical Sciences;2024-08

3. Flubendazole presents anti-tumor effects by promoting cell cycle arrest and inhibiting the invadopodia in pancreatic cancer;2024-07-17

4. Therapeutic strategies of targeting non-apoptotic regulated cell death (RCD) with small-molecule compounds in cancer;Acta Pharmaceutica Sinica B;2024-07

5. STAT5B Suppresses Ferroptosis by Promoting DCAF13 Transcription to Regulate p53/xCT Pathway to Promote Mantle Cell Lymphoma Progression;Biologics: Targets and Therapy;2024-07